For thousands of years, humans have been running an experiment. They arrived in a new landscape, started tasting plants, watching what happened, and slowly built a library of which ones could heal. A new Harvard study shows exactly where that accumulated knowledge has left the deepest marks.
Researchers analyzed over 32,000 medicinal plants from more than 357,000 vascular plant species worldwide — about 9% of all plants have documented therapeutic use. The pattern that emerged was striking: medicinal plant diversity follows a clear geography. It's lowest near the poles and richest near the equator, mirroring overall plant diversity. But some regions tell a different story entirely.
India, Nepal, Myanmar, and China have far more medicinal plants than their raw biodiversity would predict. Same with parts of Southeast Asia. These aren't accidents of climate or soil. They're the fingerprint of time. "Centuries to millennia of cultural knowledge and human interaction with plants have helped build and maintain this rich diversity," said lead researcher Nawal Shrestha, now an assistant professor at Kathmandu University. The data backs this up: regions with longer histories of human settlement consistently had more plants harvested for medicine. Time itself became a predictor.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News Detox
Then there are the gaps. The Andes, southern Africa's Cape Provinces, Madagascar, Western Australia, and New Guinea all have fewer documented medicinal plants than their biodiversity suggests they should. But here's the thing: that doesn't mean the knowledge isn't there. It means it hasn't been written down in the global databases researchers use. Local communities in these regions have accumulated their own deep medicinal knowledge — it's just not been systematized or shared beyond their own territories.
This distinction matters because it reframes what's actually at stake. We're not just losing plants. We're losing the human knowledge embedded in them. The Madagascar periwinkle, for instance, wasn't randomly screened by Western scientists — it was used in traditional medicine first. That plant has now yielded two major chemotherapy drugs. The Pacific yew's anticancer compound paclitaxel came from the same path: traditional use, then modern extraction.
"Our findings reveal areas where not just biodiversity, but priceless traditional and local medical knowledge are at risk," said Charles C. Davis, curator of vascular plants at Harvard's herbaria. The implication is clear: those cold spots on the map aren't failures. They're opportunities — if the knowledge held by local communities can be documented and preserved before it disappears.
This is already happening in some places. Indigenous communities and research institutions are partnering to record medicinal plant knowledge before it's lost to generational change and land pressures. The Harvard study essentially creates a roadmap for where that work is most urgent and most likely to yield discoveries that could benefit global health.
